Have a feature idea you'd love to see implemented? Let us know!

ILMN Illumina Inc

Price (delayed)

$141.09

Market cap

$22.38B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.95

Enterprise value

$24.11B

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights
The quick ratio has soared by 127% from the previous quarter and by 53% YoY
The gross margin has grown by 4.1% YoY and by 3.1% from the previous quarter
The equity has plunged by 64% YoY but it has increased by 48% from the previous quarter
Illumina's EPS has increased by 48% QoQ but it has decreased by 40% YoY

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
158.6M
Market cap
$22.38B
Enterprise value
$24.11B
Valuations
Price to book (P/B)
10.58
Price to sales (P/S)
5.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.49
Earnings
Revenue
$4.39B
EBIT
-$1.44B
EBITDA
-$1.05B
Free cash flow
$547M
Per share
EPS
-$9.95
Free cash flow per share
$3.44
Book value per share
$13.34
Revenue per share
$27.61
TBVPS
$28.91
Balance sheet
Total assets
$6.01B
Total liabilities
$3.89B
Debt
$2.6B
Equity
$2.13B
Working capital
$1.4B
Liquidity
Debt to equity
1.22
Current ratio
2.43
Quick ratio
1.68
Net debt/EBITDA
-1.65
Margins
EBITDA margin
-23.9%
Gross margin
63.9%
Net margin
-36.1%
Operating margin
-26.7%
Efficiency
Return on assets
-19.6%
Return on equity
-42.1%
Return on invested capital
-31.8%
Return on capital employed
-28.6%
Return on sales
-32.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
0.84%
1 week
-2.12%
1 month
-7.07%
1 year
23.77%
YTD
1.33%
QTD
8.19%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$4.39B
Gross profit
$2.81B
Operating income
-$1.17B
Net income
-$1.58B
Gross margin
63.9%
Net margin
-36.1%
The operating income has soared by 56% from the previous quarter but it has decreased by 13% YoY
Illumina's operating margin has soared by 56% from the previous quarter but it has decreased by 16% YoY
ILMN's net income is up by 48% since the previous quarter but it is down by 41% year-on-year
Illumina's net margin has increased by 47% QoQ but it has decreased by 43% YoY

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
N/A
P/B
10.58
P/S
5.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.49
Illumina's EPS has increased by 48% QoQ but it has decreased by 40% YoY
The equity has plunged by 64% YoY but it has increased by 48% from the previous quarter
The price to book (P/B) is 47% higher than the last 4 quarters average of 7.2 and 43% higher than the 5-year quarterly average of 7.4
ILMN's P/S is 49% below its 5-year quarterly average of 10.1 but 11% above its last 4 quarters average of 4.6

Efficiency

How efficient is Illumina business performance
The ROE has plunged by 141% YoY but it has grown by 35% from the previous quarter
The company's return on assets has shrunk by 100% YoY but it rose by 41% QoQ
ILMN's return on invested capital has surged by 54% since the previous quarter but it is down by 35% year-on-year
Illumina's return on sales has surged by 51% QoQ but it has decreased by 40% YoY

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 55% more than the total liabilities
The quick ratio has soared by 127% from the previous quarter and by 53% YoY
The current ratio has soared by 119% from the previous quarter and by 44% YoY
Illumina's debt is 22% higher than its equity
The equity has plunged by 64% YoY but it has increased by 48% from the previous quarter
The debt to equity is down by 38% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.